Delivery Order SPE2DB25D3022-SPE2DB25FWCPY
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $7,979.98 to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Mounjaro 5 mg/0.5 ml pens. This is a firm fixed-price delivery order with an ultimate completion date of September 12, 2025, issued under a non-competitive, non-set-aside procurement. The product will be delivered to the company's facility in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $11,046.77 delivery order to AmerisourceBergen Drug Corp for Mounjaro 5 mg/0.5 ml pens on September 3, 2025, with completion scheduled for September 4, 2025. This contract is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $7,755.60 to AmerisourceBergen Drug Corp for the supply of Mounjaro 10 mg/0.5 ml pens on August 7, 2025, with completion targeted for August 8, 2025. This is a firm fixed-price delivery order with no set-aside designation, issued under competitive procedures. The product will be supplied to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters as a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $2,586.22 to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Mounjaro 5 mg/0.5 mL pens (0.5 mL). This firm fixed-price delivery order is non-competitive and utilizes a competitively awarded indefinite delivery contract vehicle. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 25, 2025. As a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Mounjaro 10 mg/0.5 mL pens valued at $1,632.54 with an ultimate completion date of September 16, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitively awarded transaction under the company's existing contract vehicle with DLA. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a $1,088.36 delivery order to AmerisourceBergen Drug Corp for Mounjaro 5 mg/0.5 ml pen medication on July 25, 2025, with completion targeted for July 28, 2025. This firm fixed-price contract represents a non-competitive delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to the company's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains...
- The Defense Logistics Agency awarded a $3,444.33 delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Mounjaro 2.5 mg/0.5 mL pens with a completion date of August 27, 2025. This non-set-aside, firm fixed-price contract represents a single delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract vehicle with DLA Troop Support Medical. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is one of the nation's largest...
- The Defense Logistics Agency awarded a $5,441.80 delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Mounjaro 15 mg/0.5 ml pen injectors. The contract is a firm fixed-price delivery order with an ultimate completion date of September 23, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's capability to compete for...
- The Defense Logistics Agency awarded a delivery order valued at $9,379.27 to AmerisourceBergen Drug Corp for the supply of Mounjaro 5 mg/0.5 ml pens on August 18, 2025, with completion scheduled for August 19, 2025. This firm fixed price delivery order is issued without set-aside status, indicating competitive award based on open competition. The product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. This...
- The Defense Logistics Agency awarded a delivery order valued at $14,291.18 to AmerisourceBergen Drug Corp for the supply of Mounjaro 5 mg/0.5 mL pens on September 23, 2025, with a completion date of September 24, 2025. This is a firm fixed price, non-set-aside contract with performance in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply...
- SPE2DB25D3022Indefinite Delivery Contract
- SPE2DB25D3022-SPE2DB25FWCPYDelivery Order
The Defense Logistics Agency awarded a $19,487.23 delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Mounjaro 5 mg/0.5 mL pens with a completion date of September 18, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed price pricing and represents a single delivery transaction under AmerisourceBergen's larger pharmaceutical supply agreement. The product will be delivered to the company's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate operations as a major pharmaceutical distributor serving federal healthcare needs. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) designated SPE2DX with the DLA Troop Support Medical, a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. The parent IDC enables AmerisourceBergen to supply a broad range of pharmaceutical products and medical commodities to support military healthcare programs worldwide, including support for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. As a critical vendor in the federal medical procurement supply chain, AmerisourceBergen demonstrates substantial capability to fulfill diverse pharmaceutical requirements through open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $19.5k | 9/17/25 |